Artiva Biotherapeutics, Inc. Common Stock (ARTV) financials · $37.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Artiva Biotherapeutics, Inc. Common Stock (ARTV) $37.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $251.0K |
| Operating Income | -$89.8M | -$67.3M |
| Net Income | -$83.9M | -$65.4M |
| EPS (Diluted) | -$3.43 | -$5.81 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $130.9M | $209.6M |
| Current Assets | $112.7M | $188.6M |
| Cash & Equivalents | $26.7M | $40.2M |
| PP&E | $6.62M | $6.37M |
| Total Liabilities | $21.0M | $22.9M |
| Current Liabilities | $13.1M | $12.3M |
| Shareholders' Equity | $110.0M | $186.6M |
| Retained Earnings | -$330.5M | -$246.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$76.8M | -$55.0M |
| CapEx | $2.59M | $642.0K |
| Investing Cash Flow | $63.4M | -$120.5M |
| Financing Cash Flow | $9.00K | $162.2M |
| Net Change in Cash | -$13.3M | -$13.3M |
| Free Cash Flow | -$79.3M | -$55.7M |
FAQ
What is ARTV P/E and revenue?
Artiva Biotherapeutics, Inc. Common Stock (ARTV) $37.3M cap.
What is ARTV revenue?
ARTV income-statement cache has no revenue figure yet.
Is ARTV profitable?
Artiva Biotherapeutics, Inc. Common Stock last cached net income is -$83.9M (FY2025).
What are ARTV total assets?
Artiva Biotherapeutics, Inc. Common Stock last cached total assets are $130.9M (FY2025).
What is ARTV free cash flow?
Artiva Biotherapeutics, Inc. Common Stock last cached free cash flow is -$79.3M (FY2025).
Not investment advice. Cached statements, not a live tape.